3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Motor Activity
9
Neoplasms
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Obesity
3
Breast Neoplasms
3
Brain Neoplasms
3
Sarcopenia
2
Multiple Myeloma
2
Weight Loss
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Renal Insufficiency, Chronic
1
Rehabilitation Exercise
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Overweight
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Melanoma
1
Lymphoma, B-Cell
1
Lymphoma
1
Lymphedema
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Leukemia, Myeloid, Acute
1
Interventions
ruxolitinib
10
fludarabine phosphate
5
Whole-Body Irradiation
5
Cyclophosphamide
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Hydroxyurea
4
bomedemstat
3
Stem Cell Transplantation
3
Specimen Handling
3
Busulfan
3
Biopsy
3
Aspirin
3
fludarabine
2
Phlebotomy
2
Methotrexate
2
Melphalan
2
Injections
2
Azacitidine
2
venetoclax
1
veliparib
1
umbralisib
1
piperine
1
pevonedistat
1
methanesulfonic acid
1
itacitinib
1
iadademstat
1
givinostat hydrochloride
1
givinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycythemia Vera
×
Resistance Training
×
1 year
×
Clear all
NCT07518940
2026-04-09
ENERGIA
University of Turin, Italy
Phase NA
Not yet recruiting
25 enrolled